Jacobs Levy Equity Management Inc. Grows Stock Position in Seer, Inc. $SEER

Key Points

• Jacobs Levy Equity Management Inc. increased its stake in Seer, Inc. by 124.5%, owning 363,355 shares valued at $614,000 after acquiring an additional 201,491 shares.
• Seer reported an earnings per share of ($0.33), beating expectations by $0.06, and generated $4.05 million in revenue, surpassing analysts’ expectations of $3.75 million.
• CEO Omid Farokhzad sold 33,992 shares for approximately $69,344, reducing his ownership by 2.60% to 1,272,068 shares valued around $2.6 million.

Jacobs Levy Equity Management Inc. boosted its stake in Seer, Inc. (NASDAQ:SEER - Free Report) by 124.5% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 363,355 shares of the company's stock after acquiring an additional 201,491 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.61% of Seer worth $614,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. OMERS ADMINISTRATION Corp purchased a new position in Seer in the 4th quarter worth approximately $114,000. Dimensional Fund Advisors LP boosted its stake in shares of Seer by 4.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 127,711 shares of the company's stock valued at $295,000 after buying an additional 5,000 shares during the last quarter. Bank of America Corp DE boosted its stake in shares of Seer by 18.3% during the 4th quarter. Bank of America Corp DE now owns 151,337 shares of the company's stock valued at $350,000 after buying an additional 23,411 shares during the last quarter. Northern Trust Corp boosted its stake in shares of Seer by 48.7% during the 4th quarter. Northern Trust Corp now owns 155,617 shares of the company's stock valued at $359,000 after buying an additional 50,992 shares during the last quarter. Finally, Millennium Management LLC boosted its stake in shares of Seer by 9.1% during the 4th quarter. Millennium Management LLC now owns 615,812 shares of the company's stock valued at $1,423,000 after buying an additional 51,150 shares during the last quarter. Hedge funds and other institutional investors own 75.20% of the company's stock.

Seer Trading Down 0.5%

Seer stock opened at $2.05 on Friday. The stock has a market cap of $115.50 million, a P/E ratio of -1.47 and a beta of 1.57. The stock has a 50 day moving average of $2.11 and a 200-day moving average of $2.04. Seer, Inc. has a 52 week low of $1.62 and a 52 week high of $2.63.

Seer (NASDAQ:SEER - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.33) EPS for the quarter, beating the consensus estimate of ($0.39) by $0.06. The company had revenue of $4.05 million during the quarter, compared to analysts' expectations of $3.75 million. Seer had a negative return on equity of 25.10% and a negative net margin of 506.15%. As a group, equities analysts predict that Seer, Inc. will post -1.42 earnings per share for the current fiscal year.

Insider Activity at Seer

In other news, CEO Omid Farokhzad sold 33,992 shares of the stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $2.04, for a total transaction of $69,343.68. Following the completion of the transaction, the chief executive officer directly owned 1,272,068 shares in the company, valued at approximately $2,595,018.72. This represents a 2.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 11.28% of the company's stock.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

Want to see what other hedge funds are holding SEER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Seer, Inc. (NASDAQ:SEER - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.